- Home
- CVX vs ABBV Comparison
CVX vs ABBV Comparison
Compare CVX & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVX | ABBV |
|---|---|---|
| Founded | 1879 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.9B | 400.9B |
| IPO Year | 1994 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CVX | ABBV |
|---|---|---|
| Price | $201.22 | $205.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 19 |
| Target Price | $182.26 | ★ $247.06 |
| AVG Volume (30 Days) | ★ 9.7M | 5.0M |
| Earning Date | 05-01-2026 | 04-24-2026 |
| Dividend Yield | ★ 3.58% | 3.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.63 | 2.36 |
| Revenue | ★ $189,031,000,000.00 | $61,160,000,000.00 |
| Revenue This Year | $3.02 | $11.90 |
| Revenue Next Year | $5.21 | $8.13 |
| P/E Ratio | ★ $30.04 | $88.54 |
| Revenue Growth | N/A | ★ 8.57 |
| 52 Week Low | $132.04 | $164.39 |
| 52 Week High | $200.73 | $244.81 |
Technical Indicators
Market Signals| Indicator | CVX | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 75.02 | 28.67 |
| Support Level | $148.90 | $184.67 |
| Resistance Level | N/A | $231.00 |
| Average True Range (ATR) | 3.79 | 5.42 |
| MACD | 0.52 | -2.74 |
| Stochastic Oscillator | 93.17 | 4.83 |
Price Performance
Historical ComparisonAbout CVX Chevron Corporation
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.